These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1389 related articles for article (PubMed ID: 24439393)

  • 41. Treatment of invasive candidal infections: systematic review and meta-analysis.
    Gafter-Gvili A; Vidal L; Goldberg E; Leibovici L; Paul M
    Mayo Clin Proc; 2008 Sep; 83(9):1011-21. PubMed ID: 18775201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients.
    Liu F; Wu T; Wang JB; Cao XY; Yin YM; Zhao YL; Lu DP
    Transpl Infect Dis; 2013 Jun; 15(3):243-50. PubMed ID: 23496156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.
    Almyroudis NG; Segal BH
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1451-66. PubMed ID: 21133669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
    Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
    Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation.
    Herity LB; Cruz OA; Aziz MT
    J Oncol Pharm Pract; 2022 Jun; 28(4):794-804. PubMed ID: 33906508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].
    Salavert M; Jarque I
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():43-9. PubMed ID: 21420577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
    Rogers TR; Slavin MA; Donnelly JP
    Br J Haematol; 2011 Jun; 153(6):681-97. PubMed ID: 21504422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
    Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
    Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
    Karthaus M; Böhme A
    Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
    Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies.
    Marr KA
    Curr Opin Infect Dis; 2008 Aug; 21(4):409-14. PubMed ID: 18594294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
    Playford EG; Webster AC; Sorell TC; Craig JC
    Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review.
    Pechlivanoglou P; Le HH; Daenen S; Snowden JA; Postma MJ
    J Antimicrob Chemother; 2014 Jan; 69(1):1-11. PubMed ID: 23975736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.
    Robenshtok E; Gafter-Gvili A; Goldberg E; Weinberger M; Yeshurun M; Leibovici L; Paul M
    J Clin Oncol; 2007 Dec; 25(34):5471-89. PubMed ID: 17909198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
    Shang W; Feng G; Sun R; Wang X; Liu W; Zhang S; Li J; Pang X; Wang Y; Zhang W
    J Clin Pharm Ther; 2012 Dec; 37(6):652-6. PubMed ID: 22725946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
    Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
    Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials.
    Ethier MC; Science M; Beyene J; Briel M; Lehrnbecher T; Sung L
    Br J Cancer; 2012 May; 106(10):1626-37. PubMed ID: 22568999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of primary antifungal prophylaxis in patients with haematological malignancies.
    Pagano L; Caira M
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():19-26. PubMed ID: 24372659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
    Zhao YJ; Khoo AL; Tan G; Teng M; Tee C; Tan BH; Ong B; Lim BP; Chai LY
    Antimicrob Agents Chemother; 2016 Jan; 60(1):376-86. PubMed ID: 26525782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.